vimarsana.com

Page 299 - கடுமையானது எடுப்போசை சுவாச நோய்க்குறி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rigel Reports First Quarter 2021 Financial Results and Provides Business Update

Rigel Reports First Quarter 2021 Financial Results and Provides Business Update - Reported positive topline results of fostamatinib in Phase 2 clinical trial in hospitalized patients with COVID-19 - Net product sales of $12.4 million and total revenues of $81.0 million - Received upfront cash payment of $125 million from Eli Lilly for the exclusive license agreement for Rigel s RIP1 inhibitor program - Conference call and webcast today at 4:30PM Eastern Time News provided by Share this article Share this article SOUTH SAN FRANCISCO, Calif., May 5, 2021 /PRNewswire/  Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the first quarter ended March 31, 2021, including sales of TAVALISSE

Some COVID-19 long-haulers are developing a devastating syndrome

  TORONTO It began with the typical COVID-19 symptoms for Angela Griffin back in March 2020. She developed a sore throat, headache, fatigue, body aches, and a tightness in her chest. When she visited the ER, she was unable to get tested for the disease because they were only testing health-care workers, recent travellers, and close contacts of confirmed cases at the time. However, the doctors told her she was clinically positive for COVID-19 based on her symptoms and to assume she was infected. That was only the beginning of what Griffin has described as a “rollercoaster of symptoms” she has experienced since her initial illness, including migraines, body aches, chills, fever, shortness of breath, brain fog, fast heart rate, insomnia, and dizziness. 

Underreporting of Covid cases masks up to 30% of deaths in Brazil, study shows

RIO DE JANEIRO, BRAZIL - The underreporting of severe cases and deaths of Covid-19, mainly due to the lack of diagnostic tests, is masking at least 30% of deaths that do not figure in the official statistics. Had they been considered, Brazil would count 530,000 deaths, considering that last Sunday, May 2, it totaled 407,000. The conclusion is from a study by the Vital Strategies initiative, the main national Severe Acute Respiratory Syndrome (SARS) database based on Sivep-Gripe. The study researched SARS cases and deaths since the beginning of the pandemic that are listed in the official . . . To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.